Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biocapital symbols : QGEN save search
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
Published: 2022-11-21 (Crawled : 00:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
monkeypox research global test platform
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
monkeypox device global test health
Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.09%
H: 2.93%
C: 2.84%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.09%
H: 2.93%
C: 2.84%
diagnostics asco cancer diagnostic
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
Published: 2022-03-24 (Crawled : 09:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.23%
H: 0.37%
C: 0.27%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.23%
H: 0.37%
C: 0.27%
100 quantiferon milestone test
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
Published: 2022-02-07 (Crawled : 10:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
chinese approval test quantiferon
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
Published: 2022-01-25 (Crawled : 10:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.58%
H: 0.62%
C: -0.52%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.58%
H: 0.62%
C: -0.52%
covid-19 health contract system covid
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
Published: 2022-01-07 (Crawled : 09:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.37%
H: 0.0%
C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.37%
H: 0.0%
C: 0.0%
application collaboration growing platform
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
Published: 2021-12-02 (Crawled : 09:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.78%
H: 0.88%
C: 0.5%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.78%
H: 0.88%
C: 0.5%
covid quantiferon t-cell sars-cov-2 response
QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
Published: 2021-11-02 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.16%
C: -1.5%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.16%
C: -1.5%
test respiratory sars-cov-2
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions
Published: 2021-10-19 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.25%
H: 0.75%
C: 0.63%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.25%
H: 0.75%
C: 0.63%
test
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
Published: 2021-09-30 (Crawled : 00:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.17%
H: 0.72%
C: 0.02%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.17%
H: 0.72%
C: 0.02%
defense contract
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology
Published: 2021-08-10 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.0%
H: 0.11%
C: -0.92%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.0%
H: 0.11%
C: -0.92%
molecular technology sars-cov-2
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
Published: 2021-08-06 (Crawled : 18:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.35%
H: 1.94%
C: 0.6%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.35%
H: 1.94%
C: 0.6%
fda test merge authorized sars-cov-2 emergency use authorization
QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments
Published: 2021-07-07 (Crawled : 21:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.5%
H: 0.18%
C: 0.04%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 1.5%
H: 0.18%
C: 0.04%
life science research
QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
Published: 2021-05-28 (Crawled : 21:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.91%
C: -0.14%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.91%
C: -0.14%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.73%
fda lung cancer cancer fda approval diagnostic
QIAGEN Launches artus Prep as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
Published: 2021-04-20 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.97%
H: 0.64%
C: 0.6%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.97%
H: 0.64%
C: 0.6%
offering test sars-cov-2
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance
Published: 2021-04-06 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.3%
H: 1.2%
C: 0.34%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.3%
H: 1.2%
C: 0.34%
covid genomic
QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021
Published: 2021-01-20 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.15%
H: 0.8%
C: -0.44%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.15%
H: 0.8%
C: -0.44%
test submission sars-cov-2
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.